Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Albendazole + pyrantel pamoate is a combination anthelmintic medication used to treat various intestinal worm infections including roundworm, hookworm, and pinworm infections. The combination leverages two different mechanisms of action: albendazole inhibits microtubule formation in parasites, while pyrantel pamoate acts as a depolarizing neuromuscular blocking agent that causes spastic paralysis in worms. This combination has been studied particularly for treating Trichuris trichiura (whipworm) infections in school-aged children, though research indicates it may not significantly improve cure rates or egg reduction rates compared to albendazole alone for mild trichuriasis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on albendazole + pyrantel pamoate.